Becker's Healthcare November 14, 2024
Amid a decade-high surge in drug shortages, the American Medical Association has adopted new policy measures aimed at addressing the crisis.
The policy advocates for federal oversight of compounding pharmacies advertising drugs that are in shortage, the prevention of artificial drug shortages and the introduction of incentives to encourage manufacturers to invest in improving product processes.
A key focus of the AMA’s policy is the shortage of semaglutide and other GLP-1s, which have faced increased demand due to aggressive advertising, particularly...
Today's Sponsors
Today's Sponsor